Tech spin-off slashes clinical audit time by 90%, signs deals with Roche and ST Engineering

An artificial intelligence (AI) platform piloted in Singapore has helped to cut the time taken to do labour-intensive clinical audits by as much as 90 per cent.

- Lee Li Ying

Following the successful pilot, the locally based company behind the AI platform signed agreements on May 27 to expand its reach and capabilities with biotech giant Roche and engineering firm ST Engineering.

The memorandums of understanding (MOUs) were signed at the ATxSummit technology conference held at Capella Singapore.

Enigma Health, established in 2024, is a health tech spin-off from SingHealth Duke-NUS Academic Medical Centre.

Its flagship product, Enigma, is an AI platform developed by a team of clinicians and AI scientists. It is a small language model, which, when compared with the more commonly known large language model, uses less computing power, works faster, and is usually not connected to the internet, making it safer in protecting sensitive data.

Enigma was piloted at SingHealth institutions, including at the Singapore National Eye Centre (SNEC), KK Women's and Children's Hospital and the SingHealth Duke-NUS Institute of Precision Medicine.